TRDA:NASDAQ, Entrada Therapeutics, Inc.

TRDA stock overview

Entrada Therapeutics, Inc. (TRDA:NASDAQ) closed at $4.75 on October 26, 2026, up 7.71% on the day. The stock trades 71.1% below its 52-week high of $16.45 and 15.6% above its 52-week low of $4.11. Over the past year, it lost 35.0%. Entrada Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$4.75
Day change
+7.71%
Volume
617,085
Average volume
344,898
Market cap
184M+
52-week range
$4.11 – $16.45
50-day average
$6.34
200-day average
$8.91

Price action over the past year

In 252 trading sessions since October 24, 2025, TRDA closed higher on 128 days (51%). Its best day was July 29, 2026 (+12.35%) and its worst was May 7, 2026 (-57.27%). The stock moved 10% or more in a single session 6 times.

Recent signals

TRDA news

About Entrada Therapeutics, Inc.

Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases.

Similar stocks

Find more stocks like TRDA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.